Table of Contents
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Vietnam External Defibrillator Market Insights
3.1. Industry Value Chain Analysis
3.1.1. DROC Analysis
3.1.2. Growth Drivers
3.1.2.1. Rising Prevalence of Target Diseases
3.1.2.2. Rising prevalence of cardiac diseases
3.1.3. Restraints
3.1.3.1. Problems with Implanted and Automated External Defibrillators
3.1.4. Opportunities
3.1.4.1. Emerging Markets
3.1.5. Challenges
3.2. Technology Advancements/Recent Developments
3.3. Regulatory Framework
3.4. Porter's Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrants
3.4.4. Threat of Substitutes
3.4.5. Intensity of Rivalry
4. Vietnam External Defibrillator Market Overview
4.1. Market Size & Forecast, 2019-2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Product
4.2.1.1. Manual External Defibrillators
4.2.1.2. Automated External Defibrillators
4.2.1.3. Wearable Cardioverter Defibrillators
4.2.2. By End Use
4.2.2.1. Hospital
4.2.2.2. Public Access Market
4.2.2.3. Alternate Care Market
4.2.2.4. Home Healthcare
5. Competitive Landscape
5.1. List of Key Players and Their Offerings
5.2. Vietnam External Defibrillator Company Market Share Analysis, 2022
5.3. Competitive Benchmarking, By Operating Parameters
5.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
6. Impact of Covid-19 on Vietnam External Defibrillator Market
7. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
7.1. Koninklijke Philips N.V
7.2. Stryker ZOLL Medical Corporation
7.3. Nihon Kohden Corporation
7.4. ProgettiSrl
7.5. Schiller AG
7.6. Bexen Cardio
7.7. Medtronic
7.8. Abbott
7.9. Boston Scientific Corporation
7.10. BIOTRONIK SE & Co. KG
7.11. Other Prominent Players
8. Key Strategic Recommendations
9. Research Methodology
9.1. Qualitative Research
9.1.1. Primary & Secondary Research
9.2. Quantitative Research
9.3. Market Breakdown & Data Triangulation
9.3.1. Secondary Research
9.3.2. Primary Research
9.4. Breakdown of Primary Research Respondents, By Region
9.5. Assumptions & Limitations
*Financial information in case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable